Genomic Sequencing: Analyzing the DNA of a patient's tumor to identify specific genetic mutations. Biomarker Identification: Detecting biological molecules that indicate the presence or progression of cancer. Targeted Therapies: Developing drugs that specifically target the identified mutations or pathways. Clinical Trials: Testing new treatments in a controlled environment to determine their efficacy and safety.
